Harish Consul
Biongevity Enhances Longevity Strategy with Harish Consul as Chief Venture Capital Advisor
04. September 2024 09:49 ET | BioAro
Biongevity appoints Harish Consul as Chief Venture Capital Advisor, accelerating global growth with innovative precision health and longevity strategies.
KCSA_full logo_black text
Unlocking the Secrets of Immortality: KCSA Podcast Labs Dives into $43 Billion Longevity Industry
03. September 2024 15:00 ET | KCSA Strategic Communications
New York, Sept. 03, 2024 (GLOBE NEWSWIRE) -- NEW YORK, September 3, 2024 - In a world where billionaires are racing to extend human lifespan, KCSA Strategic Communications is pulling back the...
Precision Health and Longevity Summit 2024
Canada's First Precision Health and Longevity Summit Aims to Advance Global Healthspan Research
08. August 2024 09:47 ET | BioAro
Join Canada’s first Precision Health & Longevity Summit on Nov 16, 2024, at The Westin Calgary. Explore innovations in precision medicine & healthspan.
Lifeist.png
Mikra Big Summer Sale On Now, Free Gift with Each Order
18. Juli 2024 07:00 ET | Lifeist Wellness Inc.
TORONTO, July 18, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in...
Rejuvant Leader in Longevity
Rejuvant Emerges as No. 1 Longevity Solution in TruMe Labs DNA Methylation Test Results
24. Januar 2024 10:00 ET | Rejuvant
Rejuvant emerges as No. 1 longevity solution in TruMe Labs DNA methylation test results.
thumbnail_Pan-Biome-logo.png
Pan-Biome Pharmaceuticals, a startup focused on age-related diseases and increasing human healthspan, reports positive results in a preclinical trial of colitis
25. April 2023 10:00 ET | Pan-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, April 25, 2023 (GLOBE NEWSWIRE) -- Pan-Biome Pharmaceuticals, Inc, a Vancouver based preclinical biopharmaceutical company focused on age-related diseases and extending...
Chart 1
Lifeist’s Mikra Announces Successful Study Results for CELLF
13. April 2023 07:06 ET | Lifeist Wellness Inc.
TORONTO, April 13, 2023 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCQB: LFSWF), a health-tech company that leverages advancements in...
Dr. Jamie W. Wright, D.O., M.S.
Cerulean Human Health Performance Welcomes Dr. Jamie Wright as Its New Medical Director
24. Oktober 2022 07:00 ET | CERULEAN Human Health Performance
SCOTTSDALE, Ariz., Oct. 24, 2022 (GLOBE NEWSWIRE) -- Wright began his medical career in 2005 as a private practice Board-Certified Ob/Gyn. Recognizing his entrepreneurial predisposition, Dr. Wright...
SRW - NMN - Social - Post - 1080 x 1080px - 2
Popular anti-aging ingredient used by Harvard Professor has landed in New Zealand
25. September 2022 23:40 ET | SRW Laboratories
AUCKLAND, New Zealand, Sept. 25, 2022 (GLOBE NEWSWIRE) -- New Zealand health company ‘SRW Laboratories’ have introduced a stabilised form of high purity NMN (Nicotinamide Mononucleotide) to their...
CELLF Single-serve Sachet
Lifeist Subsidiary Mikra Cellular Sciences to Launch First Product “CELLF” to Combat Brain Fog and Unlock Healthy Aging, Announces U.S. Patent Application and Pre-Clinical Study
06. Dezember 2021 07:00 ET | Lifeist Wellness Inc.
- Mikra patent focusing on novel cellular therapeutic targeting systemic fatigue- Mikra partners with InVivo Biosystems for pre-clinical trials to strengthen patent application and generate further...